on-bodyinjectordosing.com domain details, SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
Description: Learn about SKYRIZI®, now approved to treat moderate to severe Crohn’s disease. See full Safety and Prescribing Information.
Domain rank: 100000000
Indexed URLs from on-bodyinjectordosing.com website (10)
The links in column here only counts links from external domains.
found date
links in
url title
url
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-19
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Adults with Moderate to Severe CD
2022-09-17
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
2022-09-17
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
SKYRIZI® (risankizumab-rzaa) for Adults with Moderate to Severe CD